Ryan Abo
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 7
- Molecular Biology top 5%
- Gene expression and cancer classification 5
- Epigenetics and DNA Methylation 4
- Bioinformatics and Genomic Networks 4
- Biological Psychiatry top 10%
- Environmental Chemistry top 5%
-
- Genetic Associations and Epidemiology 11
- Nutrition, Genetics, and Disease 4
-
- PARP inhibition in cancer therapy 6
-
- Folate and B Vitamins Research 5
- Co-authors
- Stuart S. LevineVincent L. ButtySteven R. TannenbaumJohn S. WishnokJames G. FoxKatherine Ann SchlieperJames A. SwenbergKun Lü
- Journals
- Cancer Research (8 papers)Proceedings of the National Academy of Sciences (3 papers)Pharmacogenetics and Genomics (3 papers)
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
Ryan Abo
46 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Cancer Research 804
- Molecular Biology 1.6k
- Biological Psychiatry 57
- Environmental Chemistry 145
- Health, Toxicology and Mutagenesis 199
Countries citing papers authored by Ryan Abo
This map shows the geographic impact of Ryan Abo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Abo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Abo more than expected).
Fields of papers citing papers by Ryan Abo
This network shows the impact of papers produced by Ryan Abo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Abo. The network helps show where Ryan Abo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ryan Abo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 39 | |
| 2 | 2014 | 105 | |
| 3 | 2014 | 106 | |
| 4 | Arsenic Exposure Perturbs the Gut Microbiome and Its Metabolic Profile in Mice: An Integrated Metagenomics and Metabolomics Analysisbreakdown → | 2014 | 425 |
| 5 | Braveheart, a Long Noncoding RNA Required for Cardiovascular Lineage Commitmentbreakdown → | 2013 | 733 |
| 6 | 2013 | 9 | |
| 7 | 2013 | 37 | |
| 8 | 2012 | 20 | |
| 9 | 2012 | 28 | |
| 10 | 2012 | 1 | |
| 11 | 2012 | 43 | |
| 12 | 2012 | 15 | |
| 13 | 2012 | 36 | |
| 14 | 2011 | 82 | |
| 15 | 2011 | 16 | |
| 16 | 2011 | 23 | |
| 17 | 2010 | 40 | |
| 18 | 2010 | 20 | |
| 19 | 2010 | 1 | |
| 20 | 2009 | 26 |
About Ryan Abo
Ryan Abo is a scholar working on Cancer Research, Genetics, Molecular Biology, Oncology and Rheumatology, having authored 48 papers that have together received 2.4k indexed citations. Recurring topics across this work include Genetic Associations and Epidemiology (11 papers), Cancer Genomics and Diagnostics (7 papers), PARP inhibition in cancer therapy (6 papers), Gene expression and cancer classification (5 papers), Folate and B Vitamins Research (5 papers), Nutrition, Genetics, and Disease (4 papers), Epigenetics and DNA Methylation (4 papers) and Bioinformatics and Genomic Networks (4 papers). The work is most often cited by research in Cancer Research (804 citations), Molecular Biology (1.6k citations), Biological Psychiatry (57 citations), Environmental Chemistry (145 citations) and Health, Toxicology and Mutagenesis (199 citations). Ryan Abo has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Stuart S. Levine, Vincent L. Butty, Steven R. Tannenbaum, John S. Wishnok, James G. Fox, Katherine Ann Schlieper, James A. Swenberg, Kun Lü, Robert K. Bradley and Christopher B. Burge. Their work appears in journals such as Cancer Research, Proceedings of the National Academy of Sciences, Pharmacogenetics and Genomics, Bioinformatics and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.